Cipla stock costs INR 1,329.60, 20.53 percent below its 52-week high

Cipla stock stood at INR 1,329.60 on the NSE on October 13, 2026 at 3:28 p.m. IST, up 1.40 percent versus the NSE close of October 12, 2026. The price remained 20.53 percent below the 52-week high of INR 1,673.00, making range position the clearest market measure for the session.

Results date sets the next test

Cipla's next quarterly results are scheduled for October 27, 2026, according to CNBC TV18. The date gives the market a defined point for assessing earnings, margins and the company's response to recent operating pressure.

Range and valuation in view

Cipla's current price was INR 163.90 above its 52-week low of INR 1,165.70 and INR 343.40 below its high. Trading volume reached 478,063 shares against an average volume of 1,022,053 shares, while the session price range ran from INR 1,303.00 to INR 1,329.60.

The company had a market capitalization of INR 1.1 trillion as of October 13, 2026. Its price-to-earnings ratio was 31.88 and its dividend yield was 0.01 percent. Cipla operates in healthcare, with pharmaceuticals as its industry classification.

Comparison with peers

Cipla (NSE, INR): plus 1.40 percent, P/E 31.88, market capitalization INR 1.1 trillion
Sun Pharmaceutical Industries (NSE, INR): plus 0.61 percent, P/E 35.13, market capitalization INR 4.2 trillion
Dr. Reddy's Laboratories (NSE, INR): plus 0.86 percent, P/E 31.23, market capitalization INR 1.0 trillion

Price remains below the yearly high

Cipla's 1.40 percent daily gain was smaller than the gap to its yearly high, leaving the stock 20.53 percent below that level. The company is listed on India's NSE under ticker CIPLA, while the next results date provides the next scheduled valuation point.

The latest price was INR 1,329.60 on the NSE on October 13, 2026 at 3:28 p.m. IST, up 1.40 percent versus the NSE close of October 12, 2026.

Market context: Market report BSE Sensex.

More news and analyses on Cipla stock